How Good is ICSI in Georgia? - Reproductive Specialist Explains the Principles and Applicable Boundaries

Operational Process and Core Technical Steps of ICSI

ICSI (Intracytoplasmic Sperm Injection) is a technique performed under an inverted microscope using micromanipulation to inject a single sperm directly into the oocyte cytoplasm, bypassing the natural fertilization steps of sperm-zona pellucida binding and the acrosome reaction. First successfully reported by Belgian scholar Palermo et al. in 1992, it has become the standard solution for male factor infertility.

The specific operational steps include the following core stages:

• Oocyte Preparation: After egg retrieval, cumulus cells are removed using hyaluronidase to expose the oocytes, which are then arranged in a micromanipulation dish.
• Sperm Selection: Under a 200-400x inverted microscope, morphologically normal, motile sperm are selected from the sperm suspension. For patients with severe oligoasthenoteratozoospermia or obstructive azoospermia, sperm must be retrieved from the epididymis or testicular tissue.
• Sperm Immobilization: The tail of the microinjection needle is used to gently press and slide against the midpiece of the sperm tail to immobilize it, facilitating aspiration and injection.
• Sperm Injection: The immobilized sperm is aspirated tail-first into the microinjection needle. The oocyte is positioned, and the needle is passed through the zona pellucida and oolemma to inject the sperm into the cytoplasm. Care must be taken to control the amount of cytoplasm aspirated to avoid damaging the meiotic spindle.
• Fertilization Assessment: Pronucleus formation is observed 16-18 hours after injection. Normal fertilization is indicated by the presence of two pronuclei and two polar bodies.

The entire procedure requires a highly controlled environment: the micromanipulation workstation must be equipped with a heating stage, the culture dish uses HEPES-buffered medium to maintain pH stability, and the injection time for a batch of oocytes should be limited to 3-5 minutes to minimize the oocytes' exposure time outside the incubator.

When is ICSI Indicated?

ICSI has clear medical indications and is not necessary for all assisted reproduction cases. The following situations are priority indications for ICSI:

• Severe Oligozoospermia: Sperm concentration below 5×10⁶/mL, where conventional IVF cannot guarantee sufficient sperm for egg binding.
• Severe Asthenozoospermia: Progressive motility below 10%, where sperm lack the motility to penetrate the zona pellucida.
• Severe Teratozoospermia: Normal morphology below 4% (by strict criteria), where structural abnormalities of the acrosome or tail impair fertilization.
• Obstructive Azoospermia: Sperm retrieved via epididymal aspiration or testicular biopsy are limited in number and have not undergone natural selection, necessitating ICSI for fertilization.
• Previous IVF Fertilization Failure or Low Fertilization Rate: Fertilization rate below 30% in a conventional IVF cycle, or complete fertilization failure.
• High Sperm DNA Fragmentation Rate: When DFI exceeds 30%, even with normal morphology, conventional IVF fertilization rates and embryo developmental potential decrease. ICSI can partially circumvent the obstacle of zona pellucida binding.
• Use of Frozen-Thawed Sperm: Sperm motility decreases after freeze-thawing, requiring ICSI to improve fertilization chances.
• Requirement for PGT (Preimplantation Genetic Testing): To avoid residual sperm DNA on the zona pellucida affecting test results, ICSI is the standard fertilization method in PGT cycles.

When is ICSI Not Recommended?

The following situations require caution or should not prioritize ICSI:

• Non-male Factor Infertility with Normal Previous IVF Fertilization: For patients with tubal factor, ovulatory disorders, or endometriosis, conventional IVF typically achieves fertilization rates above 70%. ICSI does not improve live birth rates and adds procedural costs and potential risks.
• Poor Oocyte Quality: ICSI can only address the issue of sperm entry into the egg; it cannot improve the quality of the egg itself. For patients with diminished ovarian reserve, abnormal oocyte morphology, or poor maturity, ICSI cannot compensate for intrinsic oocyte defects.
• Severe Oligoasthenoteratozoospermia Without Sperm DNA Fragmentation Assessment: Directly using sperm with high DFI for ICSI can lead to low fertilization rates, embryo developmental arrest, or increased miscarriage rates. The underlying cause should be treated first, or sperm selection should be optimized using methods like swim-up or density gradient centrifugation.
• Male Chromosomal Structural Abnormalities Without Genetic Counseling: Conditions such as Y-chromosome microdeletions or Robertsonian translocations require prior genetic counseling and risk assessment before deciding on the fertilization method.

Differences in ICSI Technology Among Georgian Fertility Centers

Fertility centers in Georgia exhibit certain differences in the implementation of ICSI technology, primarily in the following aspects:

When selecting a center in Georgia, it is necessary to understand the specific configuration of its embryology laboratory, the embryologist's years of experience, and whether a real-time monitoring system is in place. These factors directly influence ICSI fertilization rates, embryo developmental potential, and final outcomes.

Comparison of ICSI in Georgia with Other Countries

ICSI technology itself is a globally standardized micromanipulation technique, but the implementation environment and supporting management vary between countries:

• Compared with Western European countries (Spain, Greece, Cyprus): Some centers in Georgia have equipment configurations close to Western European levels, especially laboratories newly built or upgraded after 2020. However, embryologist training and quality control systems in Western European centers are more mature, with longer accumulated clinical management experience. Costs in Georgia are approximately 50%-65% of those in Western Europe.
• Compared with Eastern European countries (Czech Republic, Ukraine, Latvia): The development trajectory of ICSI technology in Georgia is similar to that of Eastern Europe, with laboratory construction standards often referencing EU regulations. A difference is that Georgia has fewer legal restrictions on egg and sperm donation, leading some patients to choose Georgia based on gamete availability. The Czech Republic has a more systematic national certification system for embryologist training and laboratory quality control.
• Compared with domestic centers (in China): Large domestic reproductive centers have significant advantages in ICSI procedure volume, embryologist experience accumulation, and quality control management. Georgia's advantages include fewer legal restrictions (e.g., egg donation, sperm donation, gender selection) and relatively lower overall costs. For domestic patients undergoing ICSI in Georgia, additional considerations include language communication, medical coordination, and the convenience of post-operative follow-up.

Four Key Details Most Easily Overlooked

Impact of Sperm DNA Fragmentation Rate on ICSI Outcomes

A point often overlooked by many patients and some practitioners is that even though ICSI bypasses the zona pellucida binding step, the sperm DNA fragmentation rate still significantly affects post-fertilization embryo development. After the sperm enters the oocyte cytoplasm, the egg's DNA repair mechanisms must handle the sperm's DNA damage. If the fragmentation rate is too high (DFI>30%), even with successful fertilization, there is an increased risk of elevated blastomere fragmentation, reduced blastocyst formation rate, or post-implantation miscarriage. It is recommended to routinely test the sperm DNA fragmentation rate before an ICSI cycle. If the result is high, treat the underlying cause first (e.g., varicocelectomy, antibiotic therapy, antioxidant supplementation) and wait until DFI drops below 30% before starting the cycle.

The Decisive Role of Oocyte Quality in ICSI

ICSI cannot improve oocyte quality. Some patients believe that "once the sperm gets in, pregnancy will happen," but in reality, oocyte quality determines whether the embryo can develop normally after fertilization. For women over 38 years old, with AMH below 1.0 ng/mL, or with a history of low oocyte yield during stimulation, ICSI cannot compensate for the increased rate of chromosomal aneuploidy in oocytes. In such cases, a comprehensive assessment is needed to determine whether autologous oocyte ICSI is suitable or if donor eggs should be considered.

Laboratory Air Quality and Culture Environment

The air quality of the embryology laboratory, especially the concentration of volatile organic compounds (VOCs), has a direct impact on embryo development after ICSI. Some centers in Georgia are located in older buildings in city centers, where laboratory ventilation and air filtration systems may not be as good as in newer centers. It is advisable to check whether the center is equipped with HEPA filtration and VOC adsorption systems, and whether low oxygen culture (5% O₂) is used. Low oxygen culture more closely mimics the physiological environment of the fallopian tube and has clear benefits for embryo development.

Embryologist's Operational Status and Fatigue Management

ICSI is a highly delicate manual procedure, and the embryologist's operational stability is affected by fatigue. If a center schedules a large number of ICSI procedures daily (e.g., more than 20 cycles), the embryologist's hand fatigue and decreased concentration can affect the precision of sperm immobilization and injection. A well-managed center will control the daily caseload or arrange for multiple embryologists to rotate. This point is rarely inquired about when patients choose a center, but its actual impact should not be underestimated.

Physician's Perspective: Clinical Decision-Making Logic for ICSI

As a reproductive specialist, when deciding whether to use ICSI and whether to perform it in Georgia, the following clinical decision-making pathway is followed:

1. Establish a Clear Diagnosis: Through semen analysis, sperm morphology, sperm DNA fragmentation rate, male karyotype, Y-chromosome microdeletion testing, etc., identify the specific cause and severity of male infertility.
2. Assess Female Partner's Condition: Age, AMH, antral follicle count, previous response to ovarian stimulation, uterine cavity environment, etc., to determine if the female's reproductive potential justifies an ICSI cycle.
3. Determine the Necessity of ICSI: For non-severe male factor, conventional IVF is preferred. ICSI should not be used as a routine "success rate booster."
4. Evaluate Center Conditions: If planning to perform ICSI in Georgia, assess the target center's equipment level, embryologist experience, culture system, and quality control records. In centers with suboptimal conditions, even if the ICSI procedure is completed, subsequent embryo culture and freeze-thaw steps may affect the final outcome.
5. Develop an Individualized Plan: Based on the male's sperm characteristics (e.g., severe oligozoospermia requiring early sperm retrieval and freezing, high DFI requiring pre-treatment, obstructive azoospermia requiring surgical sperm retrieval), create a specific timeline and preparation plan.

A notable clinical observation is that some patients who undergo ICSI in Georgia may face difficulties with embryo transport or re-biopsy if they need frozen embryo transfer after returning home. Therefore, the entire treatment pathway, including the plan for embryo disposition, should be clarified before starting the cycle.

Necessary Preparations and Time Planning Before ICSI

From the decision to proceed with ICSI to officially starting the cycle, at least 4-8 weeks of preparation time should be allocated. The specific schedule is as follows:

• Male Partner Workup (4-6 weeks in advance): Semen analysis (2 times, 2 weeks apart), sperm DNA fragmentation rate, karyotype, Y-chromosome microdeletion, infectious disease screening (Hepatitis B, C, HIV, Syphilis, etc.).
• Female Partner Workup (4-6 weeks in advance): AMH, FSH, LH, Estradiol, antral follicle count, thyroid function, uterine cavity assessment (e.g., ultrasound or hysteroscopy), infectious disease screening.
• Genetic Counseling (if indicated): For chromosomal abnormalities, single gene disorder carriers, or recurrent pregnancy loss, complete genetic counseling in advance to determine if PGT is necessary.
• Center Selection and Communication (2-4 weeks in advance): Confirm the target center's ICSI procedure protocol, fee structure, embryo culture plan, freeze-thaw technology, and embryo disposition policy.
• Medication Preparation and Cycle Start (1-2 weeks in advance): Arrange the ovarian stimulation protocol based on the female's menstrual cycle, and simultaneously schedule the male's sperm collection or surgical sperm retrieval date.

For patients with a high sperm DNA fragmentation rate, it is recommended to start antioxidant therapy (Coenzyme Q10, Vitamin E, Zinc, Selenium, etc.) and lifestyle adjustments (smoking cessation, limiting alcohol, avoiding high temperatures) 2-3 months in advance, and only proceed with the cycle after a repeat DFI test shows improvement.

Risks and Precautions of ICSI Technology

ICSI technology is generally safe, but the following risks require attention:

• Risk of Fertilization Failure: Even after performing ICSI, 2%-5% of cycles may result in complete fertilization failure. Causes include oocyte activation deficiency, sperm centrosome dysfunction, or technical issues.
• Risk of Oocyte Damage: The microinjection process may damage the oocyte's meiotic spindle or oolemma, leading to oocyte degeneration or embryonic chromosomal abnormalities. An experienced embryologist can keep the oocyte damage rate below 5%.
• Risk of Multipronuclear Fertilization: 1%-3% of ICSI cycles result in multipronuclear fertilization (usually tripronuclear), and these embryos cannot be used for transfer.
• Offspring Safety: Multiple large-sample studies show that the birth defect rate in ICSI offspring is slightly higher than in natural conception (approximately 1.2-1.5 times). However, considering that the ICSI population itself often has male factor infertility, it is not definitively established whether this difference is entirely due to the technique itself. Patients should be fully informed of this before the procedure.
• Risk of Freeze-Thaw Cycle Coordination: If embryos are created via ICSI in Georgia and need to be transported to another country for transfer, confirm the legal regulations of the destination country, the receiving center's acceptance conditions, and the survival rate guarantee during embryo transport.

Risk Reminder

ICSI technology cannot guarantee 100% fertilization and pregnancy. Its outcome is influenced by multiple factors including sperm quality, oocyte quality, laboratory conditions, and embryologist experience. When selecting a fertility center in Georgia, it is recommended to request and verify the laboratory's recent cycle data (including fertilization rate, oocyte damage rate, blastocyst formation rate, and freeze-thaw survival rate), rather than focusing solely on success rates in promotional materials. For patients of advanced age, with low ovarian reserve, or with other combined infertility factors, ICSI is not a universal solution. A rational choice should be made after a comprehensive evaluation. All treatment decisions should be made in consultation with the primary physician after completing a full fertility assessment and genetic counseling.